{"date":"2025-02-11","count":12,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6734-2025-02-11-1845-1b4tbma","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-02-11","time":"18:45:51","subject":"更正:公告本公司113年12月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-02-11 18:45，「更正:公告本公司113年12月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-02-11-1830-fw040o","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-02-11","time":"18:30:19","subject":"本公司股份買回計畫執行完畢","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-02-11 18:30，「本公司股份買回計畫執行完畢」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-02-11-1829-1ld7rc","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-02-11","time":"18:29:35","subject":"本公司買回股份金額達新台幣三億元以上","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-02-11 18:29，「本公司買回股份金額達新台幣三億元以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-02-11-1806-1kownc1","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-02-11","time":"18:06:32","subject":"取得高肝安全性止痛新藥SNP-810(安泰拿疼)達現行乙醯胺酚(Acetaminophen)建議使用劑量三倍(12克)之無肝毒性臨床試驗最終報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-02-11 18:06，「取得高肝安全性止痛新藥SNP-810(安泰拿疼)達現行乙醯胺酚(Acetaminophen)建議使用劑量三倍(12克)之」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-02-11-1723-mthqin","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-02-11","time":"17:23:27","subject":"公告本公司股票初次上櫃前現金增資暫定承銷價格相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-02-11 17:23，「公告本公司股票初次上櫃前現金增資暫定承銷價格相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-02-11-1722-ouqytn","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-02-11","time":"17:22:44","subject":"公告本公司董事會通過財務暨會計主管任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-02-11 17:22，「公告本公司董事會通過財務暨會計主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-02-11-1650-16y2hlf","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-02-11","time":"16:50:53","subject":"公告本公司113年11月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-02-11 16:50，「公告本公司113年11月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-02-11-1635-1roellr","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-02-11","time":"16:35:41","subject":"公告本公司董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-02-11 16:35，「公告本公司董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-02-11-1621-1hkj5dk","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-02-11","time":"16:21:19","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-02-11 16:21，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-02-11-1608-8y3vwa","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-02-11","time":"16:08:35","subject":"公告本公司董事會決議通過新設立子公司","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-02-11 16:08，「公告本公司董事會決議通過新設立子公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-02-11-1606-kxgk3x","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-02-11","time":"16:06:58","subject":"公告本公司發言人及代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-02-11 16:06，「公告本公司發言人及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2025-02-11-1551-12y2ui1","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2025-02-11","time":"15:51:05","subject":"更正本公司112年11-12月各月營收及累計營收","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2025-02-11 15:51，「更正本公司112年11-12月各月營收及累計營收」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}